NCT02605174 · Interventional trial
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
Overall registry status Completed
Phase 3
Conditions Migraine With or Without Aura
Delaware Valley sites
- Hassman Research Institute · Berlin, NJ · Camden County
First posted
Registry updated
Added to the directory